Ipca Laboratories (NSE:IPCALAB) EBIT per Share : ₹40.31 (TTM As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Ipca Laboratories EBIT per Share?

Ipca Laboratories's EBIT per Share for the three months ended in Dec. 2023 was ₹12.70. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹40.31.

During the past 12 months, the average EBIT per Share Growth Rate of Ipca Laboratories was 22.10% per year. During the past 3 years, the average EBIT per Share Growth Rate was -1.90% per year. During the past 5 years, the average EBIT per Share Growth Rate was 22.60% per year. During the past 10 years, the average EBIT per Share Growth Rate was 9.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Ipca Laboratories's EBIT per Share or its related term are showing as below:

NSE:IPCALAB' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -31.3 Med: 20.45 Max: 66.7
Current: -1.9

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Ipca Laboratories was 66.70% per year. The lowest was -31.30% per year. And the median was 20.45% per year.

NSE:IPCALAB's 3-Year EBIT Growth Rate is ranked worse than
65.61% of 852 companies
in the Drug Manufacturers industry
Industry Median: 7.95 vs NSE:IPCALAB: -1.90

Ipca Laboratories's EBIT for the three months ended in Dec. 2023 was ₹3,223 Mil.

Ipca Laboratories EBIT per Share Historical Data

The historical data trend for Ipca Laboratories's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipca Laboratories EBIT per Share Chart

Ipca Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EBIT per Share

Get a 7-Day Free Trial

22.35

29.85

55.18

45.05

31.15

Ipca Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT per Share	Get a 7-Day Free Trial															7.10	5.81	11.17	10.63	12.70

Ipca Laboratories EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Ipca Laboratories's EBIT per Share for the fiscal year that ended in Mar. 2023 is calculated as

	EBIT per Share		(A: Mar. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	7903.8	/	253.704
=	31.15

Ipca Laboratories's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	3222.9	/	253.709
=	12.70

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹40.31

Ipca Laboratories (NSE:IPCALAB) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Ipca Laboratories EBIT per Share Related Terms

Thank you for viewing the detailed overview of Ipca Laboratories's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Ipca Laboratories (NSE:IPCALAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipca Laboratories Ltd (NSE:IPCALAB) » Definitions » EBIT per Share

Traded in Other Exchanges

524494:India

Address

125, Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067

Website

https://www.ipca.com

Ipca Laboratories Ltd is a specialty and generic drug manufacturing company. The company's principal activity is Development, Manufacturing and Marketing of Pharmaceuticals Products. The company operates multiple subsidiaries with revenue generation split roughly between India and the rest of the world. Ipca's products are exported to more than 100 countries across the globe. Ipca has only one reportable primary business segment, pharmaceuticals.

Ipca Laboratories (NSE:IPCALAB) Headlines

No Headlines